|
No. of laboratories* (n = 104)
|
No. of laboratories 2007 (n = 12)
|
No. of laboratories 2012 (n = 14)
|
Azithromycin MIC breakpoints (mg/L)
|
|---|
|
S ≤
|
I
|
R >
|
|---|
|
31 (29.8%)
|
4 (33.3%)
|
4 (28.6%)
|
0.5
|
–
|
0.5
|
|
29 (27.9%)
|
0
|
6 (42.9%)
|
0.25a
|
0.5a
|
0.5a
|
|
11 (10.6%)
|
2 (16.7%)
|
1 (7.1%)
|
1
|
–
|
1b
|
|
7 (6.7%)
|
2 (16.7%)
|
0
|
0.5
|
1
|
1
|
|
6 (5.8%)
|
1 (8.3%)
|
0
|
2
|
–
|
–
|
|
6 (5.8%)
|
0
|
2 (14.3%)
|
0.25
|
–
|
0.25
|
|
1 (1.0%)
|
0
|
0
|
0.125
|
0.25–0.5
|
0.5
|
|
1 (1.0%)
|
0
|
0
|
0.125
|
0.25–1
|
1
|
|
1 (1.0%)
|
1 (8.3%)
|
0
|
0.25
|
0.5–1
|
1
|
|
1 (1.0%)
|
1 (8.3%)
|
0
|
4
| | |
|
10 (9.6%)
|
1 (8.3%)
|
1 (7.1%)
|
None given
|
- Note: Detailed interpretative MIC data was only available until 2012. Adherence to published breakpoints collected post-2012
- *Includes total number of participants at each distribution, i.e. the same laboratory will be counted at each distribution
- aCurrent EUCAST breakpoints
- bUS GISP alert value MIC (https://www.cdc.gov/std/gisp/GISP-Protocol-May-2016.pdf)
